Skip to main content

and
  1. No Access

    Protocol

    Negative-Selection Enrichment of Circulating Tumor Cells from Peripheral Blood Using the Microfluidic CTC-iChip

    The ability to isolate and analyze rare circulating tumor cells (CTCs) holds the potential to increase our understanding of cancer evolution and allows monitoring of disease and therapeutic responses through a...

    Risa Burr, Jon F. Edd, Brian Chirn, Avanish Mishra, Daniel A. Haber in Mammary Stem Cells (2022)

  2. Article

    Open Access

    A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cells

    Quiescence (G0) is a transient, cell cycle-arrested state. By entering G0, cancer cells survive unfavorable conditions such as chemotherapy and cause relapse. While G0 cells have been studied at the transcript...

    Sooncheol Lee, Douglas Micalizzi, Samuel S. Truesdell, Syed I. A. Bukhari in Genome Biology (2020)

  3. No Access

    Article

    A microfluidic device for label-free, physical capture of circulating tumor cell clusters

    The Cluster-Chip provides highly efficient and gentle capture of circulating tumor cell clusters from milliliters of unprocessed whole blood, making it possible to study how these clusters contribute to metast...

    A Fatih Sarioglu, Nicola Aceto, Nikola Kojic, Maria C Donaldson in Nature Methods (2015)

  4. No Access

    Article

    Microfluidic, marker-free isolation of circulating tumor cells from blood samples

    The ability to isolate and analyze rare circulating tumor cells (CTCs) has the potential to further our understanding of cancer metastasis and enhance the care of cancer patients. In this protocol, we describe...

    Nezihi Murat Karabacak, Philipp S Spuhler, Fabio Fachin, Eugene J Lim in Nature Protocols (2014)